Liquid Biopsy: Revolutionizing Breast Cancer Detection

According to FutureWise analysis, the market for breast biopsy in 2023 is US$1.60 billion, and is expected to reach US$3.54 billion by 2031 at a CAGR of 10.40%.

The global breast biopsy market is anticipated to experience steady growth over the next several years, projected to expand from approximately USD 2.6 billion in 2024 to around USD 5.2 billion by 2037. This represents a compound annual growth rate (CAGR) of roughly 6.9%. Short-term forecasts further underscore this positive trend, with market values expected to increase from an estimated USD 2.38 billion in 2025 to USD 3.26 billion by 2030. Several key factors are propelling this growth. Firstly, the rising incidence of breast cancer worldwide is a significant driver, with statistics indicating that early detection through biopsy can improve patient outcomes. Additionally, there is a growing awareness surrounding breast health and the importance of regular screening, which is encouraging more women to undergo biopsy procedures. Moreover, advancements in technology have led to the increasing adoption of minimally invasive and image-guided biopsy techniques. These innovations not only enhance the accuracy of diagnoses but also reduce recovery times and patient discomfort, making them more appealing to both healthcare providers and patients. Collectively, these factors are transforming the landscape of the breast biopsy market, facilitating improved diagnostic capabilities and ultimately contributing to better healthcare outcomes for individuals affected by breast cancer.

FutureWise Market Research has released a report that provides an intricate analysis of Breast Biopsy Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

Request a Free Sample @

https://www.futurewiseresearch.com/contact.aspx?rpt=9431&type=requestsample

Breast Biopsy Market Segmentation:

By Product

• Biopsy Needles
• Guidance Systems
• Biopsy Tables
• Assay Kits
• Liquid Biopsy Instrument
• Localizing Wires

By Type

• Needle Breast Biopsy
• Core Needle Biopsy
• Vaccum-Assisted Biopsy(VAB)
• Fine Needle Aspiration Biopsy(FNAB)
• Open Surgical Breast Biopsy
• Excisional
• Incisional
• Liquid Breast Biopsy
• Circulating Tumor Cell
• Circulating Tumor DNA(CTDNA)

By Guidance

• Image Guided Biopsy
• Mammography-Guided Stereotactic Biopsy
• UltraSound-Guided Biopsy
• MRI-Guided Biopsy
• Liquid Biopsy
• PCR-Based Biopsy
• NGS-Based Biopsy
• Microarray-Based Biopsy

By Application

• Early Cancer Screening
• Therapy Selection
• Treatment Monitoring
• Recurrence Monitoring

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Breast Biopsy Market:

• Hologic, Inc
• Danaher Corporation
• Argon Medical
• Becton, Dickinson and Company
• IZI Medical Products
• Merit Medical Systems
• Menarina Silicon Biosystem spa
• Scion Medical Technologies, LLC
• Medtronic
• Sterylab S.R.L
• Bioceps, Inc
• Bio-Rad Laboratories, Inc
• F.Hoffmann-la Roche Ltd
• Qiagen
• Exact Sciences Corporation
• Thermo Fisher Scientific
• Cardiff Oncology, Inc.
• Myriad Genetics, Inc.
• Illumina, Inc.
• Fluxion Biosciences, Inc

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=9431&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Breast Biopsy Market By Product, By Type, By Guidance, By Application and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com

Article source: https://article-realm.com/article/Health-Fitness/76254-Liquid-Biopsy-Revolutionizing-Breast-Cancer-Detection.html